Thanks to Jim, immune checkpoint therapy has transformed not only our institution but the entire cancer field, providing a revolutionary new treatment strategy and real hope for countless cancer patients. In addition, Jim’s story stands as one of the best examples of the importance of sustained investment in basic biomedical research.
Guest Editorial: Cancer-Letter-10.5.18